Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy. - Wikidata - wikimedia - TriplyDB

Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.

Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.

http://www.wikidata.org/entity/Q34362345

about

Extrolites of Aspergillus fumigatus and Other Pathogenic Species in Aspergillus Section Fumigati Genetic Analysis Using an Isogenic Mating Pair of Aspergillus fumigatus Identifies Azole Resistance Genes and Lack of MAT Locus's Role in Virulence Nowhere to invade: Rumex crispus and Typha latifolia projected to disappear under future climate scenarios Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species Ochratoxin production and taxonomy of the yellow aspergilli (Aspergillus section Circumdati)Rodent Models of Invasive Aspergillosis due to Aspergillus fumigatus: Still a Long Path toward Standardization.Paravertebral mushroom: identification of a novel species of Phellinus as a human pathogen in chronic granulomatous disease.Characterization of lignocellulolytic activities from a moderate halophile strain of Aspergillus caesiellus isolated from a sugarcane bagasse fermentation.Development of a clinically comprehensive database and a simple procedure for identification of molds from solid media by matrix-assisted laser desorption ionization-time of flight mass spectrometry Fungal diagnostics.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome Name Changes for Fungi of Medical Importance, 2012 to 2015.Chronic granulomatous disease: Clinical, molecular, and therapeutic aspects.Molecular screening of 246 Portuguese Aspergillus isolates among different clinical and environmental sources.A Review of Chronic Granulomatous Disease.Aspergillosis in Chronic Granulomatous Disease.Exogenous Stimulation of Type I Interferon Protects Mice with Chronic Granulomatous Disease from Aspergillosis through Early Recruitment of Host-Protective Neutrophils into the Lung.Taxonomy of Aspergillus section Petersonii sect. nov. encompassing indoor and soil-borne species with predominant tropical distribution Emerging Aspergillus Species Almost Exclusively Associated With Primary Immunodeficiencies

P2860

Q26771471-B15A62D7-14F1-4BC9-8593-F3293290ADD1 Q28546712-A6FEA1BE-F965-4652-80DE-17668BA524BB Q30660088-9AF5803B-1E13-4BCF-9CF6-2BDD767530DE Q30841118-44C4D372-12EB-4C7A-8F23-FC4B3B6FDCFC Q30876887-59B4A8F8-617C-4120-B83A-0C7F1D04F853 Q33689767-57399BC2-58A5-4B03-9DBC-B1A05E5854A8 Q33900017-9BFE4AC6-1854-4549-AE9C-49422543EFAB Q34097536-42B81E38-C7D3-42F2-A379-B94F4B3FA973 Q34523418-98642B20-2503-427D-AC04-C3D3E87B0B2D Q35137799-D8429F17-3308-4E48-9486-BB1EEACC0C3C Q37287794-37A34758-2E2F-48D0-BE22-129D12122EAF Q37581912-ED7CABE0-9FFA-4871-8F19-534D46B47CF8 Q38672968-7CF39581-CA6B-4BCC-8E36-0188F55FE7A3 Q42214481-C3176F74-8983-49F6-9B64-04B7E6B3C7AB Q45874911-E5130ADE-48E5-4FAA-ABAA-CF3AD84E2985 Q47645142-0782A9BE-FA85-47E2-8AD0-3AFEDBB528C5 Q51148937-963793D0-DFDB-4B78-9305-49617CA07AA6 Q56568436-BB03733F-838E-4361-9C97-11D69D779766 Q56993243-EE6B2861-8980-41FF-94EC-BC262ECEFC83

P2860

Aspergillus tanneri sp. nov., a new pathogen that causes invasive disease refractory to antifungal therapy.

http://www.wikidata.org/entity/Q34362345

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@ast

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@en

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@nl

type

label

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@ast

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@en

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@nl

prefLabel

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@ast

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@en

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@nl

P1433

Q34362345-B3E3C059-611B-42CD-9515-17349F159AB8

P1476

Q34362345-0CFE6DBE-105B-4A2C-B8D9-3F557B43E80A

P2093

Q34362345-051D2AF7-F03B-4D19-960F-1D00D8F7A41E

Q34362345-31690538-0C63-40EE-96AB-30B78B7DA366

Q34362345-6D587672-DAAB-4593-B878-707FA490A01C

Q34362345-791F58AF-92D0-4BC8-90BB-CF9B9A0CD874

Q34362345-7E140920-2D23-4B2E-BD7D-D623216A0E2A

Q34362345-8BE49F01-E187-41B1-BEEC-AE4F6CE09DD3

Q34362345-8DAA0421-67BE-433B-9AB9-6EF9EF5B99BF

Q34362345-8DB770D5-96FD-4882-A4C3-1AB1A5214FD7

Q34362345-A3535C3A-3495-4BB1-9B29-93637784F12C

Q34362345-A3A4357E-EF23-47EF-9FD1-6BAA02FB8FD4

P2860

Q34362345-0B1B8669-D9D0-4203-9BFD-5477579846FF

Q34362345-0B8FD6E6-BA73-4896-B3D1-2FA13C6597EE

Q34362345-16A057E5-9511-4FFA-83A9-F76493E36381

Q34362345-1A7E114F-33E5-4A42-B611-33695E86F9F6

Q34362345-21443F6F-F80D-4477-BF94-2EB60C9C9000

Q34362345-217B7EBF-A40C-4428-AE71-9AF212C18614

Q34362345-24656D95-A677-4D36-A08A-FBBC1AF1CE31

Q34362345-263DC2D1-93BA-438A-A32A-3FAFC49395FF

Q34362345-27681D16-08A1-4418-9CF8-08333282290D

Q34362345-2D27E187-347F-4FF4-8BEF-7E0A142D3BA3

P304

Q34362345-5A15FE33-8527-474B-B24E-13B39FB0D7A7

P31

Q34362345-18397302-A022-4C09-BAF3-BC12C27EAD1F

P356

Q34362345-ED5B6CDD-0186-4F46-B289-38BF8EFBB6DC

P407

Q34362345-570C662A-0F59-46DA-B99F-8D8898D72440

P433

Q34362345-47F16005-FB16-4647-9C38-367EAFBF3E32

P478

Q34362345-56D1BD42-9A18-4F24-8862-193309768F16

P577

Q34362345-9E6E877E-53E5-423C-970C-AFF5F71FEC84

P698

Q34362345-292E9ADC-DEB1-4F6B-B916-2F8D42E7E8A4

P921

Q34362345-A3AB5198-FE5F-4294-B1F6-8115E6176758

P932

Q34362345-8B9A7895-A6E7-46A1-A6C0-4AF35330947F

P356

P1433

Journal of Clinical Microbiology

P1476

Aspergillus tanneri sp. nov., ...... ractory to antifungal therapy.

@en

P2093

Adrian M Zelazny

http://www.w3.org/2001/XMLSchema#string

Christa S Zerbe

http://www.w3.org/2001/XMLSchema#string

Christina M Henderson

http://www.w3.org/2001/XMLSchema#string

Glenn Nardone

http://www.w3.org/2001/XMLSchema#string

Gregory Riedlinger

http://www.w3.org/2001/XMLSchema#string

Janyce A Sugui

http://www.w3.org/2001/XMLSchema#string

Kyung J Kwon-Chung

http://www.w3.org/2001/XMLSchema#string

Les Folio

http://www.w3.org/2001/XMLSchema#string

Lily P Clark

http://www.w3.org/2001/XMLSchema#string

Stephen W Peterson

http://www.w3.org/2001/XMLSchema#string

P2860

Sequencing of Aspergillus nidulans and comparative analysis with A. fumigatus and A. oryzae

Efficacy of a technique for exposing the mouse lung to particles aspirated from the pharynx

Identification and characterization of an Aspergillus fumigatus "supermater" pair

Multiple sequence alignment with the Clustal series of programs

MODELTEST: testing the model of DNA substitution

MrBayes 3: Bayesian phylogenetic inference under mixed models

MRBAYES: Bayesian inference of phylogenetic trees

TreeView: an application to display phylogenetic trees on personal computers

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

Aspergillus section Versicolores: nine new species and multilocus DNA sequence based phylogeny

P304

3309-3317

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.01509-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22855513

http://www.w3.org/2001/XMLSchema#string

P921

P932

3457449

http://www.w3.org/2001/XMLSchema#string